By Peter Nurse
Investing.com -- Stocks in focus in premarket trade on Tuesday, October 6th. Please refresh for updates.
Alteryx (NYSE:AYX) stock rose 22% after the data-analytics software company announced a new chief executive and raised its sales guidance.
Iovance Biotherapeutics (NASDAQ:IOVA) stock slumped 20% after announcing late Monday that it will likely not apply for a license for a cancer therapy it is developing until 2021.
Spartan Energy (NYSE:SPAQ) stock rose 4.3% after the special purpose acquisition company announced plans to combine with Fiskers, an electric car company.
Biontech (NASDAQ:BNTX) stock soared 10% and Pfizer (NYSE:PFE) stock rose 1% after the EU fast tracked the review process for the potential Covid-19 vaccine the two companies are developing together.
Moderna (NASDAQ:MRNA) stock fell 1.8% after Reuters reported that not enough patients from ethnic minorities had enrolled in its coronavirus vaccine trial, slowing its progress.
- Vir Biotechnology (NASDAQ:VIR) stock rose 19% after announcing that its Covid-19 antibody drug, that it's developing with GlaxoSmithKline (NYSE:GSK), has begun a phase 3 trial.
Sonos (NASDAQ:SONO) stock fell 3.2% after reports that tech giant Apple (NASDAQ:AAPL) is dropping the wireless speaker maker’s products from its stores.
Alexion (NASDAQ:ALXN) stock rose 1.5% after the pharmaceutical company said it expects to raise its 2020 revenue outlook by more than $200 million, and to return $3 billion to shareholders over the next three years.
Macy’s (NYSE:M) stock rose 0.8% after the largest U.S. department store operator signed a deal to invest in Swedish payments group Klarna, betting on the "buy now, pay later" online payments market.
Group 1 Automotive (NYSE:GPI) stock rose 2% after the car retailer offered positive third quarter guidance, unveiled a $200 million share buyback program and said it will reinstate its quarterly cash dividend.
FuelCell (NASDAQ:FCEL) stock rose 9%, rebounding after Monday’s hefty selloff, as it disputed claims made by a short-selling company, Night Market Research, that it lost two contracts in its backlog and didn't disclose that in a fundraising completed last week. It said the report contained “factual inaccuracies”.
Costco (NASDAQ:COST) stock rose 1% after Barclays (LON:BARC) upgraded its investment stance to “overweight” from “equal weight”, citing customer traffic levels and sustainable profit margin expansion.